AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
| 0.6905 Delayed Data As of 3:59pm ET |  +0.1104 / +19.03%Today’s Change | 0.57 Today|||52-Week Range 7.60 | -69.45% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -24.4M | -43.2M | -51.5M | -47.1M | |
| Depreciation | 2.0M | 2.1M | 1.7M | 575.0K | ||
| Total Other Cash Flow | 6.9M | 14.0M | 16.3M | 15.6M | ||
| Funds From Operations | -15.5M | -27.1M | -33.5M | -30.9M | ||
| Funds From/For Other Operating Expenses | 4.4M | 2.3M | -3.7M | -1.9M | ||
| Net Cash Flow - Operating Activities | -20.0M | -29.4M | -29.8M | -29.1M | ||
| Investing | Increase In Investments | -7.3M | -996.0K | -7.6M | -30.6M | |
| Decrease In Investments | 16.9M | 6.5M | 0.00 | 20.5M | ||
| Capital Expenditures | -1.5M | -3.7M | -2.4M | -819.0K | ||
| Net Cash Flow Investing | 8.2M | 1.8M | -10.0M | -10.9M | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 61.2M | 0.00 | 0.00 | -- | ||
| Long Term Debt Reduction | -4.5M | 0.00 | -3.5M | -7.7M | ||
| Net Proceeds Stock Sale | 3.2M | 179.0K | 16.0M | 82.7M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | -- | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 215.0K | 205.0K | 204.0K | 0.00 | ||
| Net Cash Flow - Financing | 59.6M | -26.0K | 12.3M | 75.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 47.9M | -27.6M | -27.4M | 35.1M | ||
